Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers.
Saved in:
| Title: | Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers. |
|---|---|
| Authors: | Albaret MA; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France., Paré A; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Maxillofacial and Plastic surgery, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France., Malet L; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France., De Souza G; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France., Lavergne E; Biostatistics Unit, Centre Léon Bérard, 69373 Lyon, France., Goga D; Department of Maxillofacial and Plastic surgery, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France., De Pinieux G; Department of Pathology, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France., Castellier C; Department of Pathology, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France., Swalduz A; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Medicine, Centre Léon Bérard, 69373 Lyon, France., Robin V; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France., Lavergne V; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France., Mertani HC; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France., Treilleux I; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Pathology, Centre Léon Bérard, 69373 Lyon, France., Vermot-Desroches C; IDD BIOTECH, Bâtiment Accinov, 317 avenue Jean Jaurès, 69007, Lyon, France., Diaz JJ; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Electronic address: jean-jacques.diaz@lyon.unicancer.fr., Saintigny P; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Medicine, Centre Léon Bérard, 69373 Lyon, France. Electronic address: pierre.saintigny@lyon.unicancer.fr. |
| Source: | Translational oncology [Transl Oncol] 2021 Jan; Vol. 14 (1), pp. 100878. Date of Electronic Publication: 2020 Sep 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33010552 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Albaret+MA%22">Albaret MA</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Paré+A%22">Paré A</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Maxillofacial and Plastic surgery, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France.<br /><searchLink fieldCode="AU" term="%22Malet+L%22">Malet L</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22De+Souza+G%22">De Souza G</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Lavergne+E%22">Lavergne E</searchLink>; Biostatistics Unit, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Goga+D%22">Goga D</searchLink>; Department of Maxillofacial and Plastic surgery, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France.<br /><searchLink fieldCode="AU" term="%22De+Pinieux+G%22">De Pinieux G</searchLink>; Department of Pathology, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France.<br /><searchLink fieldCode="AU" term="%22Castellier+C%22">Castellier C</searchLink>; Department of Pathology, CHRU of Tours, 37170 Chambray-lés-Tours, France; University of François Rabelais, School of Medicine, Tours F-37032, France.<br /><searchLink fieldCode="AU" term="%22Swalduz+A%22">Swalduz A</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Medicine, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Robin+V%22">Robin V</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Lavergne+V%22">Lavergne V</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Mertani+HC%22">Mertani HC</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Treilleux+I%22">Treilleux I</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Pathology, Centre Léon Bérard, 69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Vermot-Desroches+C%22">Vermot-Desroches C</searchLink>; IDD BIOTECH, Bâtiment Accinov, 317 avenue Jean Jaurès, 69007, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Diaz+JJ%22">Diaz JJ</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Electronic address: jean-jacques.diaz@lyon.unicancer.fr.<br /><searchLink fieldCode="AU" term="%22Saintigny+P%22">Saintigny P</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France; Department of Translational Research and Innovation, Centre Léon Bérard, 69373 Lyon, France; Department of Medicine, Centre Léon Bérard, 69373 Lyon, France. Electronic address: pierre.saintigny@lyon.unicancer.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101472619%22">Translational oncology</searchLink> [Transl Oncol] 2021 Jan; Vol. 14 (1), pp. 100878. <i>Date of Electronic Publication: </i>2020 Sep 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Neoplasia+Press%22">Neoplasia Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101472619 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1936-5233 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219365233%22">19365233 </searchLink><i>NLM ISO Abbreviation: </i>Transl Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33010552 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.tranon.2020.100878 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100878 Titles: – TitleFull: Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Albaret MA – PersonEntity: Name: NameFull: Paré A – PersonEntity: Name: NameFull: Malet L – PersonEntity: Name: NameFull: De Souza G – PersonEntity: Name: NameFull: Lavergne E – PersonEntity: Name: NameFull: Goga D – PersonEntity: Name: NameFull: De Pinieux G – PersonEntity: Name: NameFull: Castellier C – PersonEntity: Name: NameFull: Swalduz A – PersonEntity: Name: NameFull: Robin V – PersonEntity: Name: NameFull: Lavergne V – PersonEntity: Name: NameFull: Mertani HC – PersonEntity: Name: NameFull: Treilleux I – PersonEntity: Name: NameFull: Vermot-Desroches C – PersonEntity: Name: NameFull: Diaz JJ – PersonEntity: Name: NameFull: Saintigny P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2021 Jan Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1936-5233 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Translational oncology Type: main |
| ResultId | 1 |
